Article
Target analysis of the experimental measles therapeutic AS-136A.
Antimicrobial agents and chemotherapy - 1 Sept 2009
Yoon Jeong-Joong, Krumm Stefanie A, Ndungu J Maina, Hoffman Vanessa, Bankamp Bettina, Rota Paul A, Sun Aiming, Snyder James P, Plemper Richard K
Abstract excerpt
No effective therapeutic is currently in place for improved case management of severe measles or the rapid control of outbreaks. Through high-throughput screening, we recently identified a novel small-molecule class that potently blocks activity of the measles virus (MeV) RNA-dependent RNA polymerase (RdRp) complex in transient replicon assays. However, the nature of the block in RdRp activity and the physical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
